Last edition
News about "advanced prostate cancer"
Astellas-Vir Partnership Advances Dual-Masked T-Cell Engager for Advanced Prostate Cancer
Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to develop and commercialize VIR-5500, an investigational PRO-XTEN dual-masked CD3 T-cell engager (TCE) targeting prostate-specific membrane antigen (PSMA) for the treatment of prostate cancer.
Advanced Prostate Cancer | 25/02/2026 | By Darshana | 159
Zydus Receives Final Approval from USFDA for Leuprolide Acetate Injection
Zydus has secured final USFDA approval for its Leuprolide Acetate injection, a multiple-dose formulation indicated for the palliative treatment of advanced prostate cancer.
Advanced Prostate Cancer | 15/11/2025 | By Dineshwori | 191
Foresee Pharmaceuticals has received US FDA approval for CAMCEVI ETM (21 mg) as a treatment for advanced prostate cancer.
Advanced Prostate Cancer | 30/08/2025 | By Mrinmoy Dey | 445
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy